SCHEMBL676629

SCHEMBL676629

COc1cc(Cl)ccc1Oc1ccc(Cl)cc1Cl

nearest known ligand 0.73

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TTR P02766 7/20 0.73
SLC6A2 P23975 9/20 0.58
SLC6A3 Q01959 7/20 0.58
NR1I2 O75469 1/20 0.58
LMNA P02545 1/20 0.58
PGR P06401 1/20 0.58
HSP90AA1 P07900 1/20 0.58
ADORA3 P0DMS8 1/20 0.58
MAPT P10636 1/20 0.58
HSPA5 P11021 1/20 0.58
HPGD P15428 1/20 0.58
CBR1 P16152 1/20 0.58
TBXA2R P21731 1/20 0.58
AGTR1 P30556 1/20 0.58
SLC6A4 P31645 9/20 0.54
KCNH2 Q12809 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12850975 0.91 TTR (0.67) TTRSLC6A2SLC6A3NR1I2LMNA
SCHEMBL4015064 0.87 TTR (0.67) TTRSLC6A2SLC6A3NR1I2LMNA
SCHEMBL196490 0.85 TTR (0.62) TTRSLC6A2SLC6A3NR1I2LMNA
SCHEMBL29687129 0.85 TTR (0.62) TTRSLC6A2SLC6A3NR1I2LMNA
SCHEMBL13236279 0.85 TTR (1.00) TTRSLC6A2SLC6A3NR1I2LMNA
SCHEMBL7186092 0.85 TTR (0.75) TTRSLC6A2SLC6A3NR1I2LMNA
SCHEMBL3365226 0.84 SLC6A4 (0.64) TTRSLC6A2SLC6A3NR1I2LMNA
SCHEMBL13264608 0.84 TTR (0.76) TTRSLC6A2SLC6A3NR1I2LMNA
Ammonia Solution, Strong SCHEMBL4261558 0.83 TTR (0.61) TTRSLC6A2SLC6A3NR1I2LMNA
SCHEMBL2127233 0.83 TRPV4 (0.55) TTRSLC6A2SLC6A3LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6133483-A Process for the production of 2,4,4'-trichloro-2'-methoxydiphenyl ether CLEARY THOMAS F (US) 2000-10-17 US claimed
US-8541556-B1 Lignin derivatives and uses thereof EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) 2013-09-24 US disclosed
US-20130231295-A1 LIGNIN DERIVATIVES AND USES THEREOF EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) 2013-09-05 US disclosed
US-8278400-B2 Antifouling materials containing cationic polysiloxanes NDSU RESEARCH FOUNDATION (US) 2012-10-02 US disclosed
US-8278400-B2 Antifouling materials containing cationic polysiloxanes NDSU RESEARCH FOUNDATION (US) 2012-10-02 US disclosed
US-8053535-B2 Polysiloxanes with anti-fouling activity NDSU RESEARCH FOUNDATION (US) 2011-11-08 US disclosed
US-20100204399-A1 ANTIFOULING MATERIALS CONTAINING CATIONIC POLYSILOXANES NDSU RESEARCH FOUNDATION 2010-08-12 US disclosed
US-20100204399-A1 ANTIFOULING MATERIALS CONTAINING CATIONIC POLYSILOXANES NDSU RESEARCH FOUNDATION 2010-08-12 US disclosed
US-7771833-B2 Anti-fouling materials containing cationic polysiloxanes NDSU RESEARCH FOUNDATION (US) 2010-08-10 US disclosed
US-7771833-B2 Anti-fouling materials containing cationic polysiloxanes NDSU RESEARCH FOUNDATION (US) 2010-08-10 US disclosed
US-20090018276-A1 Polysiloxanes with anti-fouling activity NDSU RESEARCH FOUNDATION 2009-01-15 US disclosed
US-20090018276-A1 Polysiloxanes with anti-fouling activity NDSU RESEARCH FOUNDATION 2009-01-15 US disclosed
US-20070042199-A1 Anti-fouling materials containing cationic polysiloxanes NDSU RESEARCH FOUNDATION 2007-02-22 US disclosed
US-20070042199-A1 Anti-fouling materials containing cationic polysiloxanes NDSU RESEARCH FOUNDATION 2007-02-22 US disclosed
US-7163923-B2 Bactericides, fungicides, viricides CELMED ONCOLOGY (USA), INC. (CA) 2007-01-16 US disclosed
US-6133483-A Process for the production of 2,4,4'-trichloro-2'-methoxydiphenyl ether CLEARY THOMAS F (US) 2000-10-17 US disclosed
US-6133483-A Process for the production of 2,4,4'-trichloro-2'-methoxydiphenyl ether CLEARY THOMAS F (US) 2000-10-17 US disclosed
US-6133483-A Process for the production of 2,4,4'-trichloro-2'-methoxydiphenyl ether CLEARY THOMAS F (US) 2000-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231295-A1 LIGNIN DERIVATIVES AND USES THEREOF DCXR, LCT, LSS TTR 4141/4885SLC6A2 4500/4885SLC6A3 4582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.